Skip to content

An exploratory trial of the effect of milk peptide-containing food on lipid oxidation during exercise.

An exploratory trial of the effect of milk peptide-containing food on lipid oxidation during exercise: a randomized, single-blind, cross-over study. - An exploratory trial of the effect of milk peptide-containing food on lipid oxidation during exercise: a randomized, single-blind, cross-over study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055202
Enrollment
40
Registered
2025-07-31
Start date
2024-08-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male adults

Interventions

A single intake of 2 bottles of milk peptide-containing beverage A single intake of 2 bottles of placebo beverage A single intake of 2 bags of milk protein powder and 2 bottles of placebo beverage A s

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Male subjects between the ages of 20 and less than 40 years. 2. Subjects who have an exercise habits. 3. Subjects who have received a full explanation of the study, can understand the contents, and can give a written consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who exercise for competitive purposes such as participating in a tournament. 2. Subjects with extremely irregular eating habits, such as those with dietary restrictions (e.g., carbohydrate restriction, vegetarianism, etc.) 3. Subjects who have irregular life rhythms, such as shift workers and late-night workers 4. Subjects who regularly use foods for specified health use, foods with functional claims, supplements, medicines, or quasi-drugs that may affect energy metabolism 5. Subjects who have a smoking habit 6. Subjects who have participated in other clinical trials within the past 3 months and those who are currently participating in other clinical trials. 7. Subjects who suffer from or have a history of serious cardiovascular, hepatic, renal, respiratory, endocrine, or metabolic disorders. 8. Subjects with a history of chest pain or syncope 9. Subjects who have an abnormal electrocardiogram and are judged by a physician to have a problem with exercise. 10. Subjects who have back pain, arthralgia, lumbar hernia, diseases of the lower limbs, or palpitations on exertion. 11. Subjects with drug allergy or food allergy. 12. Subjects who are judged by the investigator or sub-investigator to be inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Lipid oxidation during exercise

Secondary

MeasureTime frame
Carbohydrate oxidation, energy expenditure, and respiratory exchange ratio during exercise, and physical fatigue after exercise

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Clinical Planning Department

cpcc-contact@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026